PubMed COVID-19 Clinical Care
38611 - 38620 of 57753 results found
Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
Description
To search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed
Work-related psychosocial challenges and coping strategies among nursing workforce during the COVID-19 pandemic: a scoping review
Description
CONCLUSIONS: The study recommends regular counselling and support for all nurses working at the frontline to help them better cope with the devastating effects of the pandemic so that they could build resilience towards future pandemics.
KDM5 Family Demethylase Inhibitor KDOAM-25 Reduces Entry of SARS-CoV-2 Pseudotyped Viral Particles into Cells
Description
We studied the effect of KDM5 family demethylase inhibitors (JIB-04, PBIT, and KDOAM-25) on the penetration of SARS-CoV-2 pseudotyped viruses into differentiated Caco-2 cells and HEK293T cells with ACE2 hyperexpression. The above drugs were not
Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust
Description
CONCLUSIONS: There are diverse underlying factors that influence an individual's trust in vaccines, which means trust categories and demographic characteristics cannot be used as monolithic identifiers. Assessing vaccine trust provides insights into
Proliferative Diabetic Retinopathy Requiring Vitrectomy Over Clinic Management During COVID-19 - Impact of Delayed Care
Description
CONCLUSION: Patients with more severe PDR and greater delay in appointments due to the COVID-19 pandemic were more likely to require vitrectomy for proliferative complications. Patient-directed rescheduling was identified as the main driver of care
Therapeutic Benefits of Melatonin Against COVID-19
Description
The assumption of the pineal hormone melatonin as a therapeutic use for COVID-19 affected people seems promising. It's intake has shown significant improvement in the patients' conditions. Higher melatonin titres in children may provide a protective
Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia
Description
BACKGROUND: Severe COVID-19 is associated with innate immunopathology, and CD14, a proximal activator of innate immunity, has been suggested as a potential therapeutic target.
